iANTHUS CAPITAL HOLDINGS (ITHUF) EBITDA (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly EBITDA came in at -$2.3 million in Q1 2026, down 13.98% year-on-year from -$2.7 million in Q1 2025, and up 39.58% quarter-over-quarter from -$3.8 million in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) EBITDA (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed EBITDA across 7 years of filings, most recently posting -$2.3 million for Q1 2026.
- EBITDA for Q1 2026 came in at -$2.3 million, down 13.98% year-over-year; the trailing twelve-month figure through Mar 2026 was -$15.7 million (down 564.33% YoY), and the FY2025 annual result was -$8.4 million, down 341.59% from the prior year.
- EBITDA came in at -$2.3 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, up from -$3.8 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $10.6 million in Q4 2023 to a low of -$45.4 million in Q2 2022.
- The 5-year median for EBITDA is -$5.0 million (2024), against an average of -$8.7 million.
- Across the five-year window, EBITDA tumbled 4968.81% in 2022 and surged 124.15% in 2023, its largest moves.
- iANTHUS CAPITAL HOLDINGS's EBITDA stood at -$43.9 million in 2022, then soared by 124.15% to $10.6 million in 2023, then sank by 89.37% to $1.1 million in 2024, then tumbled by 436.17% to -$3.8 million in 2025, then jumped by 39.58% to -$2.3 million in 2026.
- The last three EBITDA figures came in at -$2.3 million (Q1 2026), -$3.8 million (Q4 2025), and -$4.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -681,231.97 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 185.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -67.29 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 81.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -98.81 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | -2.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.29 Mn |
| Dec 31, 2025 | -3.79 Mn |
| Sep 30, 2025 | -4.25 Mn |
| Jun 30, 2025 | -5.37 Mn |
| Mar 31, 2025 | -2.01 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | -1.26 Mn |
| Jun 30, 2024 | -225,000.00 |
| Mar 31, 2024 | -4.96 Mn |
| Dec 31, 2023 | 10.61 Mn |
| Sep 30, 2023 | -8.53 Mn |
| Jun 30, 2023 | -5.83 Mn |
| Mar 31, 2023 | -9.33 Mn |
| Dec 31, 2022 | -43.93 Mn |
| Sep 30, 2022 | -13.72 Mn |
| Jun 30, 2022 | -45.43 Mn |
| Mar 31, 2022 | -9.38 Mn |
| Dec 31, 2021 | -18.33 Mn |
| Sep 30, 2021 | -4.78 Mn |
| Jun 30, 2021 | 933,000.00 |